miralax
Generic: polyethylene glycol 3350
Labeler: bayer healthcare llc.Drug Facts
Product Profile
Brand Name
miralax
Generic Name
polyethylene glycol 3350
Labeler
bayer healthcare llc.
Dosage Form
POWDER, FOR SOLUTION
Routes
Active Ingredients
polyethylene glycol 3350 17 g/17g
Manufacturer
Identifiers & Regulatory
Product NDC
11523-7234
Product ID
11523-7234_3ac22f1f-b34c-0c18-e063-6394a90a9742
Product Type
HUMAN OTC DRUG
Marketing Category
NDA
Application Number
NDA022015
Listing Expiration
2026-12-31
Marketing Start
2007-02-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
115237234
Hyphenated Format
11523-7234
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
miralax (source: ndc)
Generic Name
polyethylene glycol 3350 (source: ndc)
Application Number
NDA022015 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 17 g/17g
Packaging
- 17 g in 1 PACKET (11523-7234-1)
- 119 g in 1 BOTTLE, PLASTIC (11523-7234-2)
- 238 g in 1 BOTTLE, PLASTIC (11523-7234-3)
- 510 g in 1 BOTTLE, PLASTIC (11523-7234-4)
- 17 g in 1 PACKET (11523-7234-6)
Packages (5)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3ac22f1f-b34c-0c18-e063-6394a90a9742", "openfda": {"nui": ["N0000010288", "N0000175811", "N0000009871"], "upc": ["0041100820716", "0041100564542"], "unii": ["G2M7P15E5P"], "rxcui": ["876193", "876195"], "spl_set_id": ["d69ce3d4-7ca4-4fe3-b49e-6655e48d6963"], "pharm_class_pe": ["Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "pharm_class_epc": ["Osmotic Laxative [EPC]"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "manufacturer_name": ["Bayer HealthCare LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "17 g in 1 PACKET (11523-7234-1)", "package_ndc": "11523-7234-1", "marketing_start_date": "20070201"}, {"sample": false, "description": "119 g in 1 BOTTLE, PLASTIC (11523-7234-2)", "package_ndc": "11523-7234-2", "marketing_start_date": "20070201"}, {"sample": false, "description": "238 g in 1 BOTTLE, PLASTIC (11523-7234-3)", "package_ndc": "11523-7234-3", "marketing_start_date": "20070201"}, {"sample": false, "description": "510 g in 1 BOTTLE, PLASTIC (11523-7234-4)", "package_ndc": "11523-7234-4", "marketing_start_date": "20070201"}, {"sample": false, "description": "17 g in 1 PACKET (11523-7234-6)", "package_ndc": "11523-7234-6", "marketing_start_date": "20070201"}], "brand_name": "MiraLAX", "product_id": "11523-7234_3ac22f1f-b34c-0c18-e063-6394a90a9742", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "11523-7234", "generic_name": "Polyethylene Glycol 3350", "labeler_name": "Bayer HealthCare LLC.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "MiraLAX", "active_ingredients": [{"name": "POLYETHYLENE GLYCOL 3350", "strength": "17 g/17g"}], "application_number": "NDA022015", "marketing_category": "NDA", "marketing_start_date": "20070201", "listing_expiration_date": "20261231"}